Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00529451
Status:
COMPLETED
Last Update Posted:
2011-03-25
First Post:
2007-09-12
Brief Title:
Safety and Efficacy of Aliskiren 300 mg 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
Sponsor:
Novartis
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2008-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-09-12
First Submit QC Date:
September 13 2007
Study First Post Date:
2007-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-03-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-02-28
Last Update Post Date:
2011-03-25
Last Update Post Date Type:
ESTIMATED